HALOZYME THERAPEUTICS INC shareholders Q3 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
SHAKER INVESTMENTS LLC/OH 52,531$2,006,6841.11%
SECTORAL ASSET MANAGEMENT INC 146,000$5,577,2001.09%
HighMark Wealth Management LLC 31,290$1,195,2780.99%
Stephens Investment Management Group LLC 1,454,707$55,569,8070.91%
Future Fund LLC 8,566$327,2210.91%
GW&K Investment Management, LLC 2,344,305$89,5520.90%
TEALWOOD ASSET MANAGEMENT INC 45,806$1,7500.90%
DOHENY ASSET MANAGEMENT /CA 24,178$9240.90%
Aurora Investment Counsel 35,261$1,346,9710.89%
Verity Asset Management, Inc. 31,310$1,196,0420.88%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.